Theodoros Vassilakopoulos
Overview
Explore the profile of Theodoros Vassilakopoulos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1098
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sachanas S, Vassilakopoulos T, Angelopoulou M, Papageorgiou S, Spanoudakis E, Bouzani M, et al.
Mediterr J Hematol Infect Dis
. 2025 Mar;
17(1):e2025014.
PMID: 40084092
New targeted therapies have revolutionized the treatment landscape in CLL. Biological features, patient characteristics and preferences and the safety profile of each treatment option should be taken into consideration for...
2.
Papaioannou A, Loukides S, Vassilakopoulos T, Tzanakis N, Kostikas K, Hillas G
Int J Chron Obstruct Pulmon Dis
. 2025 Mar;
20:457-471.
PMID: 40041472
Background: In recent years, COPD treatment has become more personalized considering specific patient's characteristics. Aim And Methods: We have performed a DELPHI consensus project to assess the level of consensus...
3.
Toumpanakis D, Vassilakopoulou V, Gu W, Mizi E, Chatzianastasiou A, Richard V, et al.
Am J Respir Cell Mol Biol
. 2025 Jan;
PMID: 39761600
Iron regulatory protein 2 (IRP2), a post-transcriptional regulator of cellular iron metabolism has been associated with susceptibility to chronic obstructive pulmonary disease (COPD). Resistive breathing (RB) is the hallmark of...
4.
Nikolaou V, Koumprentziotis I, Papadavid E, Patsatsi A, Diavati S, Tsimpidakis A, et al.
Int J Dermatol
. 2024 Nov;
PMID: 39526550
Background: Primary cutaneous B-cell lymphomas (PCBCLs) are rare cutaneous neoplasms with limited literature regarding treatment options and associated treatment outcomes. This study aimed to investigate and present real-world treatment outcomes...
5.
Chatzikonstantinou T, Scarfo L, Minga E, Karakatsoulis G, Chamou D, Kotaskova J, et al.
Hemasphere
. 2024 Sep;
8(9):e70004.
PMID: 39290716
No abstract available.
6.
Papaioannou A, Hillas G, Loukides S, Vassilakopoulos T
ERJ Open Res
. 2024 Jun;
10(3).
PMID: 38887682
COPD is a major healthcare problem and cause of mortality worldwide. COPD patients at increased mortality risk are those who are more symptomatic, have lower lung function and lower diffusing...
7.
Chatzikonstantinou T, Scarfo L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, et al.
EClinicalMedicine
. 2023 Nov;
65:102307.
PMID: 38033506
Background: Patients with chronic lymphocytic leukemia (CLL) have a higher risk of developing other malignancies (OMs) compared to the general population. However, the impact of CLL-related risk factors and CLL-directed...
8.
Voudouris D, Horianopoulou M, Apostolopoulou Z, Chryssanthopoulos C, Bardopoulou M, Maridaki M, et al.
Metabolites
. 2023 Oct;
13(10).
PMID: 37887399
Non-alcoholic fatty liver disease (NAFLD) is a very common liver disease associated with obesity, unhealthy diet, and lack of physical exercise. Short-term aerobic or resistance exercise has been shown to...
9.
Toumpanakis D, Glynos C, Schoini P, Vassilakopoulou V, Chatzianastasiou A, Dettoraki M, et al.
Int J Chron Obstruct Pulmon Dis
. 2023 Oct;
18:2321-2333.
PMID: 37876659
Introduction: Resistive breathing (RB) is characterized by forceful contractions of the inspiratory muscles, mainly the diaphragm, resulting in large negative intrathoracic pressure and mechanical stress imposed on the lung. We...
10.
Panagopoulos P, Georgakopoulou V, Pezoulas V, Malagari K, Fotiadis D, Goules A, et al.
Clin Exp Rheumatol
. 2023 Jun;
42(2):337-343.
PMID: 37382448
Objectives: To evaluate pulmonary and small airway function in patients with idiopathic inflammatory myopathies (IIM) and make comparisons between patients with and without interstitial lung disease (ILD). Methods: Newly diagnosed...